COMMUNIQUÉS West-GlobeNewswire

Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

24/07/2024 - 22:05

Trial projected to be initiated shortly following receipt of drug product by trial sites NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

24/07/2024 - 22:01

CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

Un troisième produit de cannabis thérapeutique approuvé au Portugal pour Tilray Medical

24/07/2024 - 20:17

L’extrait de cannabis Solução Oral THC10:CBD10 conçu par Tilray sous la forme d’une solution orale est désormais approuvé pour un usage médical au Portugal CANTANHEDE, Portugal, 24 juill. 2024 (GLOBE NEWSWIRE) -- Tilray [...]

The Foundation for Sarcoidosis Research Awards $300,000 to Support Early-Career Investigators Through the Sarcoidosis Research Fellowship Grant

24/07/2024 - 19:16

CHICAGO, July 24, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce that Dr. Greer Waldrop, University of California, San Francisco, and Dr. Miles Hagner, University of Iowa, [...]

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

24/07/2024 - 18:00

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Leuven, BELGIUM – 24 July, 2024 – 06.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in [...]

Spineway a Gold Sponsor at the SILACO Congress in Mexico - Organization of a special event with Latin American distributors

24/07/2024 - 18:00

Press release Ecully, July 24, 2024 – 6 p.m. Spineway a Gold Sponsor at the SILACO Congress in Mexico Organization of a special event with Latin American distributors The Spineway Group, a specialist in innovative [...]

Spineway Gold sponsor du congrès SILACO au Mexique - Organisation d’un évènement dédié avec les distributeurs d’Amérique Latine

24/07/2024 - 18:00

Communiqué de presse Ecully, le 24 juillet 2024 – 18h Spineway Gold sponsor du congrès SILACO au Mexique Organisation d’un évènement dédié avec les distributeurs d’Amérique Latine Le groupe Spineway, spécialiste des [...]

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

24/07/2024 - 16:52

PALO ALTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

ConSynance Therapeutics Announces U.S. FDA Grants Rare Pediatric Disease Designation to CSTI-500, a Potential First-in-Class Therapy for Prader-Willi Syndrome

24/07/2024 - 16:00

RENSSELAER, N.Y., July 24, 2024 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies for rare central nervous system (CNS) disorders, today [...]

New SPECT Study Unveils Significant Brain Activity Differences in Depression

24/07/2024 - 15:59

Research Highlights Specific Brain Areas with Increased Activity in Depressed Patients COSTA MESA, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Researchers in a groundbreaking neuroimaging study have discovered that [...]

REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples

24/07/2024 - 15:30

CLEARWATER, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, is thrilled to announce that a significant distributor in the CPAP industry has [...]

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

24/07/2024 - 15:00

The sole focus of CPC’s position and lawsuit against XWELL’s entrenched Board of Directors (the “Entrenched Directors”) is to provide shareholders with an opportunity to elect a competing slate of directors to XWELL’s [...]

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program

24/07/2024 - 15:00

PHOENIX, July 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ) , a leading commercial-stage biotechnology company focused on a [...]

Viemed Healthcare Announces Date and Time for Conference Call

24/07/2024 - 15:00

LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]

Helio Genomics to Participate in the 2024 UBS Genomic Medicine Summit

24/07/2024 - 15:00

IRVINE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today [...]

The Broken Brown Egg and Progyny Announce the 2024 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building

24/07/2024 - 14:59

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and The Broken Brown Egg, a nonprofit supporting BIPOC [...]

AIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy

24/07/2024 - 14:50

OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of [...]

Revolo Announces New Data Further Validating the Upstream Mechanism of Action and Subcutaneous Administration of ‘1104

24/07/2024 - 14:45

Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component involved in the mechanism of action of ‘1104 First-in-class upstream approach uniquely affects [...]

Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter

24/07/2024 - 14:30

DURHAM, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) , (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced [...]